Organization
Thomas Marron
1 clinical trial
Clinical trial
A Phase 1b/2 Trial of Dupilumab Given in Conjunction With PD-1 or PD-L1 Blockade in the Treatment of Relapsed/Refractory Metastatic NSCLCStatus: Recruiting, Estimated PCD: 2024-09-01
1 clinical trial